Richard Z. Cheng, MD, PhD, ABAARM
Director of the Medical & Scientific Advisory Board to the
International Intravenous Vitamin C China Epidemic Medical Support Team
Editor-in-Chief, Orthomolecular Medicine News Service, China Edition
Board of Editors, Orthomolecular Medicine News Service
ITM BIO: Dr. Richard Z. Cheng
Working closely with the International Society for Orthomolecular Medicine and the Orthomolecular Medicine NEWS Service to promote public awareness of orthomolecular medicine and Integrative Medicine in the prevention and treatment of the COVID-19 pandemic, Dr. Cheng has helped to make Vitamin C a worldwide topic, continuing the lifetime passion and devotion of both Drs. Linus Pauling and Abram Hoffer, the two giants who created the concept of orthomolecular medicine and founded the ISOM organization.
"Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?" Medicine in Drug Discovery Vol. 5. (2020)
"Protected Population Immunity, not a Vaccine, is the Way to Stop Covid-19 Pandemic"Journal of Clinical Immunology & Immunotherapy 6: 025. (May 27, 2020)
“Ascorbate as Prophylaxis and Therapy for COVID-19—Update From Shanghai and U.S. Medical Institutions” - Global Advances in Health and Medicine: Vol. 9. (July 20, 2020)
Dr. Cheng interview with CGTN America on the need for a “Protected
Population Immunity” strategy to fight new outbreaks of Covid-19.
As the Director of the Medical & Scientific Advisory Board to the International Intravenous Vitamin C China Epidemic Medical Support Team, Dr. Richard Z. Cheng has been highly sought after by global media and has coordinated online video conferences with medical experts from around the world to discuss preliminary results of IV vitamin C treatments. Video recordings of Dr. Cheng’s global interviews can be seen at: https://www.brighteon.com/channels/rzcheng